Terms: = Bone cancer AND TRIM24, O15164, 8805, ENSG00000122779, TIF1ALPHA, TF1A, TIF1A, hTIF1, Tif1a, TIF1, RNF82, PTC6
6 results:
1. TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumors.
Yoon JY; Jiang W; Orr CR; Rushton C; Gargano S; Song SJ; Modi M; Hozack B; Abraham J; Mallick AB; Brooks JSJ; Rosenbaum JN; Zhang PJ
Cancer Genet; 2021 Nov; 258-259():74-79. PubMed ID: 34583232
[TBL] [Abstract] [Full Text] [Related]
2. BMP8A promotes survival and drug resistance via Nrf2/trim24 signaling pathway in clear cell renal cell carcinoma.
Yu YP; Cai LC; Wang XY; Cheng SY; Zhang DM; Jian WG; Wang TD; Yang JK; Yang KB; Zhang C
Cancer Sci; 2020 May; 111(5):1555-1566. PubMed ID: 32128917
[TBL] [Abstract] [Full Text] [Related]
3. Therapeutic effects of human monoclonal PSMA antibody-mediated trim24 siRNA delivery in PSMA-positive castration-resistant prostate cancer.
Shi SJ; Wang LJ; Han DH; Wu JH; Jiao D; Zhang KL; Chen JW; Li Y; Yang F; Zhang JL; Zheng GX; Yang AG; Zhao AZ; Qin WJ; Wen WH
Theranostics; 2019; 9(5):1247-1263. PubMed ID: 30867828
[No Abstract] [Full Text] [Related]
4. PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia.
Zhang J; Xiang Z; Malaviarachchi PA; Yan Y; Baltz NJ; Emanuel PD; Liu YL
Cell Signal; 2018 Oct; 50():72-79. PubMed ID: 29964149
[TBL] [Abstract] [Full Text] [Related]
5. High prevalence of late adverse events in malignant bone tumour survivors diagnosed at adult age.
van de Luijtgaarden AC; Kapusta L; Bellersen L; Bokkerink JP; Kaal SE; Versleijen-Jonkers YM; Schreuder HW; van der Graaf WT
Neth J Med; 2014 Dec; 72(10):516-22. PubMed ID: 26219756
[TBL] [Abstract] [Full Text] [Related]
6. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.
Pillon M; Aricò M; Basso G; Locatelli F; Citterio M; Micalizzi C; Testi AM; Barisone E; Nardi M; Lombardi A; Rondelli R; Rosolen A;
Pediatr Blood Cancer; 2011 Apr; 56(4):544-50. PubMed ID: 21298738
[TBL] [Abstract] [Full Text] [Related]
